| Israele | Turchia | Austria | |
| Trattamento complesso del sarcoma di Ewing | - | da $30,000 | da $55,000 |
Bookimed non aggiunge costi extra ai prezzi di Trattamento complesso del sarcoma di Ewing. Le tariffe provengono dai listini ufficiali delle cliniche. Pagherai direttamente in clinica per la tua Trattamento complesso del sarcoma di Ewing al tuo arrivo.
Bookimed si impegna per la tua sicurezza. Lavoriamo solo con strutture che mantengono elevati standard internazionali in Trattamento complesso del sarcoma di Ewing e hanno le licenze necessarie per servire pazienti internazionali in tutto il mondo.
Bookimed offre assistenza esperta gratuita. Un coordinatore medico personale ti supporta prima, durante e dopo il trattamento, risolvendo qualsiasi problema. Non sarai mai solo nel tuo percorso di Trattamento complesso del sarcoma di Ewing.
Specializzato nel trattamento del sarcoma con oltre 25 anni di esperienza presso il Sourasky Medical Center, con un focus sul sarcoma di Ewing.
Dr. Ronit El Hasid is the Head of Pediatric Oncohematology and Oncology at Dana Dwek Children’s Hospital (Sourasky). She specializes in bone marrow and umbilical blood transplantation and has conducted over 300 transplantations and published 50 papers and 40 reports. She is a member of American Association for Hematology and Israeli Society for Pediatric Hematooncology, and has previously practiced in the City of Hope Hospital (Los-Angeles) and other medical centers in Israel.
Dr. Dror Levin is a senior pediatrician and director of the blood disorder and bone cancer (sarcoma) treatment departments at Children's Hospital "Dana" and Medical Center "Sourasky" respectively. He is a specialist in pediatric medicine, hematology, and oncology, with additional experience studying abroad at the Rizzoli Orthopaedic Institute in Italy.
Dr. Sternheim Amir is an experienced orthopaedic surgeon. He specializes in orthopaedic oncology, joint replacement, and complex hip and knee reconstruction. He is known for using advanced 3D technology and computer-assisted methods. These tools help him plan surgeries with high precision, especially for predicting femur fractures in patients with metastatic disease.
Dr. Amir has published many research papers and has spoken at major medical conferences. His main interests are sarcoma and metastatic bone cancer. He has received several awards, such as the Outstanding Resident Award at Tel-Aviv Medical Center. He has also earned grants from the Israeli Cancer Society and the University of Toronto. Dr. Amir is an active member of MSTS, CTOS, and ISOLS, which shows his strong reputation in the field.